Everfortune

Everfortune (Stock code: 6841.TW) is a new start-up company that originated from China Medical University (CMU). It has access to a large medical database from CMU hospital, which enables it to develop AI applications for various disciplines and diseases that are relevant to clinical needs. The core technologies of Everfortune consist of natural language processing (NLP), convolutional neural network (CNN), recurrent neural network (RNN) and others. The company focuses on the fields of "neurology", "cardiology" and "oncology". Its mission is to pursue the continuous innovation of big data and artificial intelligence in the domains of intelligent medicine and precision medicine.